ApoB vs LDL Cholesterol: What Is the Difference?

?Written by: London Blood Tests Editorial Team

Published: 31st of July

LDL cholesterol and apolipoprotein B, usually shortened to ApoB, both provide information about the lipoproteins that can contribute to atherosclerosis. They do not, however, measure exactly the same thing.

LDL cholesterol estimates how much cholesterol is being carried within LDL particles. ApoB provides an indication of the total number of potentially atherogenic lipoprotein particles circulating in the blood.

For most people, a standard cholesterol lipid profile remains the appropriate first test. ApoB may add useful information when the LDL cholesterol result does not appear to match the person’s wider cardiovascular or metabolic risk.

London Blood Tests does not offer LDL cholesterol as a standalone product. LDL cholesterol is reported as part of the broader Cholesterol Lipid Profile. A standalone Apolipoprotein B test is available when ApoB has been specifically requested or may provide additional clinical context.

ApoB and LDL cholesterol at a glance

• LDL cholesterol measures the amount of cholesterol carried in LDL particles.

• ApoB estimates the number of circulating atherogenic lipoprotein particles.

• Two people can have similar LDL cholesterol results but different ApoB concentrations.

• ApoB may be useful when triglycerides are raised or metabolic risk is present.

• A full lipid profile remains the usual first step in UK cardiovascular assessment.

• ApoB complements rather than automatically replaces LDL cholesterol.

• Neither result provides a complete assessment of heart attack or stroke risk.

• Fasting is not routinely required for a standard lipid profile or ApoB test.

What does a standard lipid profile measure?

Cholesterol and triglycerides cannot travel freely through the bloodstream. They are transported inside particles called lipoproteins.

A standard lipid profile usually includes:

• Total cholesterol

• HDL cholesterol

• Triglycerides

• LDL cholesterol

• Non-HDL cholesterol

• Cholesterol ratios

Some values are measured directly, while others may be calculated from the measured results.

NICE defines a full lipid profile as total cholesterol, HDL cholesterol and triglyceride measurements, together with calculated LDL cholesterol and non-HDL cholesterol. LDL does not always need to be measured through a separate direct assay. (NICE: Cardiovascular disease risk assessment and lipid modification)

Total cholesterol

Total cholesterol measures cholesterol across several different lipoprotein groups.

The standalone Total Cholesterol test provides a basic measurement, but it cannot show how the cholesterol is distributed between LDL, HDL and other particles.

A total cholesterol result can therefore be misleading when viewed in isolation. A higher result may partly reflect a favourable HDL level, while a seemingly acceptable total result can still conceal raised LDL, triglycerides or non-HDL cholesterol.

For cardiovascular assessment or treatment monitoring, a full lipid profile is normally more useful than total cholesterol alone.

What is LDL cholesterol?

LDL cholesterol, written as LDL-C on many laboratory reports, estimates how much cholesterol is being transported within low-density lipoprotein particles.

LDL particles can enter the wall of an artery. Over time, retained cholesterol and inflammatory processes can contribute to the formation of atherosclerotic plaque.

This is why LDL-C remains a principal target in cardiovascular prevention and cholesterol-lowering treatment guidelines. The 2025 European Society of Cardiology and European Atherosclerosis Society update retained LDL-C as the main lipid treatment target. (ESC/EAS: Dyslipidaemia guidance)

LDL-C is an important result, but it reflects the amount of cholesterol inside the particles rather than the exact number of particles present.

What is ApoB?

Apolipoprotein B is a structural protein found on several types of atherogenic lipoprotein.

These include:

• LDL particles

• Very-low-density lipoprotein particles

• Intermediate-density lipoproteins

• Remnant lipoproteins

• Lipoprotein(a)

Each circulating atherogenic particle contains an ApoB molecule. Measuring ApoB therefore provides an estimate of how many of these particles are present.

The Apolipoprotein B test measures ApoB as an individual biomarker.

ApoB is not a scan and does not show whether plaque is already present. It is a blood marker associated with the burden of cholesterol-carrying particles that may enter the arterial wall.

Cholesterol content versus particle number

A simple way to understand the difference is to imagine vehicles carrying cargo.

• LDL-C represents the amount of cholesterol cargo being transported.

• ApoB represents approximately how many atherogenic vehicles are carrying it.

Some particles carry more cholesterol than others.

One person may have a relatively small number of cholesterol-rich particles. Another may have a larger number of particles, each carrying less cholesterol. Their LDL-C results could be similar, but their ApoB results may differ.

This mismatch is known as discordance.

What is LDL-C and ApoB discordance?

LDL-C and ApoB are concordant when both results suggest a similar level of lipid-related risk.

They are discordant when one appears relatively favourable and the other does not.

Examples include:

• LDL-C within an expected range but raised ApoB

• LDL-C falling during treatment while ApoB remains relatively elevated

• Raised triglycerides with a larger number of cholesterol-depleted particles

• Low LDL-C but a higher-than-expected atherogenic particle concentration

Discordance does not mean that either result is necessarily incorrect. The tests are measuring different aspects of the same lipoprotein system.

Research suggests that ApoB may provide additional cardiovascular-risk information when it does not agree with LDL-C or non-HDL cholesterol. (European Heart Journal: ApoB and cardiovascular risk)

Is ApoB better than LDL cholesterol?

Not in every situation.

ApoB may provide a more direct estimate of atherogenic particle number, but LDL-C remains:

• Widely available

• Well understood

• Included in major treatment guidelines

• Supported by extensive clinical-trial evidence

• The principal lipid-lowering treatment target in current European guidance

ApoB is best viewed as a complementary marker. It may clarify risk in selected patients, but it does not make LDL-C irrelevant and is not required for every routine cholesterol assessment.

In the UK, NICE continues to base routine lipid assessment and treatment monitoring mainly on:

• Full lipid profiles

• LDL cholesterol

• Non-HDL cholesterol

• Overall cardiovascular risk

Who may benefit from an ApoB test?

An ApoB measurement may be particularly useful when someone has:

• Raised triglycerides

• Type 2 diabetes

• Insulin resistance

• Obesity

• Metabolic syndrome

• Established cardiovascular disease

• LDL-C that appears inconsistent with the wider clinical picture

• Residual cardiovascular risk despite treatment

• A clinician’s request for more detailed lipoprotein assessment

These conditions can be associated with a larger number of particles carrying relatively less cholesterol per particle. In that situation, LDL-C alone may underrepresent the total atherogenic particle burden.

An ApoB test should not be ordered simply because it sounds more advanced. For many people, the results from a standard lipid profile are sufficient for initial assessment and treatment decisions.

What is non-HDL cholesterol?

Non-HDL cholesterol is calculated by subtracting HDL cholesterol from total cholesterol.

It includes cholesterol transported in:

• LDL

• VLDL

• Intermediate-density lipoproteins

• Remnant particles

• Lipoprotein(a)

Non-HDL cholesterol therefore captures cholesterol across a wider range of potentially atherogenic particles than LDL-C alone.

It does not directly estimate particle number in the same way as ApoB. However, it is widely available and can be calculated from a standard lipid profile without another laboratory assay.

NICE uses non-HDL cholesterol when assessing the response to lipid-lowering treatment. For many patients, non-HDL cholesterol provides useful additional information without requiring an ApoB test.

ApoB, LDL-C and non-HDL cholesterol compared

No single marker should be used without considering the rest of the cardiovascular picture.

What if you have a family history of heart disease?

A strong family history of premature heart attack or stroke deserves wider assessment than an ApoB test alone.

Depending on the history and previous results, a clinician may consider:

• A full lipid profile

• Assessment for familial hypercholesterolaemia

• Lipoprotein(a)

• ApoB

• Blood pressure

• Diabetes testing

• Smoking status

• Kidney function

• Overall cardiovascular risk

Lipoprotein(a), or Lp(a), is largely genetically determined and is a separate cardiovascular-risk marker. European guidance increasingly supports measuring it at least once in adulthood, particularly where family history or unexplained cardiovascular risk is present.

ApoB does not replace Lp(a) testing or an assessment for familial hypercholesterolaemia.

Which London Blood Tests option may be appropriate?

Total Cholesterol

The Total Cholesterol test measures one marker.

It may be useful when total cholesterol has been specifically requested, but it is not a substitute for a full lipid profile when a detailed cardiovascular assessment or treatment review is required.

Cholesterol Lipid Profile

The Cholesterol Lipid Profile is normally the appropriate conventional starting point.

It may be suitable for:

• Routine cholesterol assessment

• Investigating raised cholesterol

• Reviewing triglycerides

• Calculating LDL-C and non-HDL cholesterol

• Baseline testing before lipid-lowering treatment

• Monitoring treatment response

• Assessing someone with a family history of cardiovascular disease

London Blood Tests does not offer LDL cholesterol as an individual standalone test. The LDL result is included within this broader profile.

Apolipoprotein B

The Apolipoprotein B test may be added when particle burden is clinically relevant.

It may provide useful additional information where:

• Triglycerides are elevated

• Diabetes or metabolic syndrome is present

• LDL-C and the wider risk profile appear inconsistent

• A healthcare professional has specifically requested ApoB

• Cardiovascular risk remains a concern despite apparently satisfactory LDL-C

ApoB is usually most informative when interpreted alongside a full lipid profile rather than completely on its own.

What about VLDL and LDL subfraction testing?

London Blood Tests also lists VLDL Cholesterol and LDL7 Subfractions as more specialised options.

VLDL cholesterol reflects cholesterol carried within triglyceride-rich VLDL particles. In routine practice, VLDL-C is often estimated from triglycerides rather than measured through a distinct direct assay. Confirm the laboratory method and clinical reason before selecting it.

LDL subfraction testing separates LDL particles according to size and density. It may provide specialist information, but major guidelines do not generally recommend it for routine initial cholesterol assessment.

Neither test is automatically more useful than a standard lipid profile with ApoB where appropriate.

Do you need to fast?

Fasting is not routinely required for either:

• A standard lipid profile

• ApoB testing

NICE states that a fasting sample is not mandatory for a full lipid profile.

A fasting test may still be requested when:

• Triglycerides are substantially raised

• A previous non-fasting result was difficult to interpret

• Comparable fasting measurements are required

• Other blood tests being collected at the same appointment require fasting

• The clinician or laboratory has provided specific instructions

Drink water normally unless instructed otherwise. Do not stop prescribed medicines before testing unless a healthcare professional has advised you to do so.

Can ApoB replace a cardiovascular-risk assessment?

No.

ApoB, LDL-C and non-HDL cholesterol assess lipid-related risk. They do not account for every factor that contributes to heart attack or stroke.

A complete assessment may also consider:

• Age

• Blood pressure

• Smoking

• Diabetes

• Kidney disease

• Family history

• Existing cardiovascular disease

• Weight and metabolic health

• Relevant medicines

• Other medical conditions

UK clinicians may use validated cardiovascular-risk tools, such as QRISK3, within an appropriate clinical setting. Treatment decisions should be based on the overall risk profile rather than one blood marker.

When should you seek medical advice?

Arrange a clinical review if:

• Cholesterol is substantially raised.

• Triglycerides are very high.

• ApoB is above the laboratory range or individual treatment target.

• You have diabetes, high blood pressure or kidney disease.

• You already have cardiovascular disease.

• A close relative had a heart attack or stroke at a young age.

• Familial hypercholesterolaemia may be present.

• You are considering starting, stopping or changing cholesterol medication.

NICE recommends specialist assessment when total cholesterol is above 9.0 mmol/L or non-HDL cholesterol is above 7.5 mmol/L, even when there is no known family history of premature coronary disease.

Very high triglycerides may also require urgent clinical review.

Where can you arrange ApoB and cholesterol testing in London?

Private ApoB and cholesterol blood testing is available through London Blood Tests partner clinics in:

• Knightsbridge

• Holborn

• Paddington

• Gants Hill

Home and hotel blood collection may also be available, subject to location and appointment availability.

When comparing cholesterol blood tests in London, check:

• Whether the test measures total cholesterol only or provides a complete lipid profile

• Whether LDL-C and non-HDL cholesterol are reported

• Whether triglycerides are included

• Whether ApoB is relevant to the clinical question

• Whether fasting has been requested

• Whether professional interpretation is available

For most people, a full lipid profile is the most appropriate first step. ApoB can then be added when the clinical history or standard results suggest that particle number may provide additional information.

Frequently asked questions

Does London Blood Tests offer LDL cholesterol on its own?

No. LDL cholesterol is not offered as a standalone product. LDL-C is reported within the Cholesterol Lipid Profile.

What is the main difference between LDL-C and ApoB?

LDL-C estimates how much cholesterol is being carried in LDL particles. ApoB estimates the total number of ApoB-containing atherogenic particles.

Is ApoB more accurate than LDL cholesterol?

ApoB may provide additional information when LDL-C does not reflect the total particle burden. It is not universally superior, and LDL-C remains the principal treatment target in current guidance.

Should I choose ApoB or a lipid profile?

A full lipid profile is generally the appropriate starting point. ApoB may be added when triglycerides are raised, metabolic risk is present or the standard results do not match the wider clinical picture.

Is total cholesterol enough?

Total cholesterol provides only a broad overview. A full lipid profile is more useful because it includes or allows calculation of LDL-C, HDL cholesterol, triglycerides and non-HDL cholesterol.

Can LDL cholesterol be normal while ApoB is raised?

Yes. This may happen when cholesterol is distributed across a greater number of particles that each carry less cholesterol.

Do I need to fast for ApoB?

Fasting is not normally required for ApoB. Follow any preparation instructions supplied for other tests being collected at the same appointment.

Is ApoB the same as Lipoprotein(a)?

No. ApoB reflects the number of several atherogenic particle types. Lipoprotein(a) is a specific genetically influenced particle and is measured separately.

Can ApoB diagnose heart disease?

No. ApoB is a cardiovascular-risk marker. It cannot show whether arteries are narrowed or diagnose a heart attack, stroke or coronary disease.

Book an ApoB or cholesterol blood test in London

London Blood Tests offers complete lipid profiles and standalone ApoB measurement through London clinics and home or hotel appointments.

For most people, the Cholesterol Lipid Profile is the correct starting point because it provides the standard cholesterol and triglyceride measurements used in UK cardiovascular assessment.

The standalone ApoB test may add useful information where atherogenic particle number is particularly relevant or where LDL-C does not fully match the person’s metabolic or cardiovascular-risk profile.

The most appropriate test is the one that answers a defined clinical question and is interpreted alongside the person’s overall health—not necessarily the test with the most advanced name.

References

1. NICE NG238: Cardiovascular disease risk assessment and lipid modification

2. ESC/EAS Guidelines for the management of dyslipidaemias

3. European Heart Journal: Apolipoprotein B and cardiovascular risk

4. European Atherosclerosis Society: Quantifying atherogenic lipoproteins

5. European Atherosclerosis Society: Non-fasting lipid profiles

Medical disclaimer: This article provides general educational information and does not replace individual cardiovascular assessment, diagnosis or treatment. Speak to a GP or another appropriately qualified healthcare professional about abnormal lipid results, medication or personal cardiovascular risk.